Sponsor

Razor Genomics Inc.

United States 111 10th Avenue South Suite 102 Room 123, 37203-3821, United States

About the sponsor

Razor Genomics Inc. is active in non-small cell lung cancer research, with a specific focus on patients who have undergone complete surgical resection and have early-stage disease. Its clinical activity centers on the non-squamous subtype of NSCLC, reflecting interest in postoperative disease management and risk assessment.

Completely resected stage I or IIA NSCLC
Non-squamous lung cancer
Postoperative lung cancer care

The sponsor’s research landscape includes collaboration across multiple sites in the United States and other active trial regions, supporting clinical evaluation in early-stage thoracic oncology.

About Specializations

Razor Genomics Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage I, Non-small cell lung cancer stage II, Lung neoplasm malignant, among others.

All trials